Merck & Co., Inc. Increase (Decrease) in Inventories
Merck & Co., Inc. (MRK) reported Increase (Decrease) in Inventories of $1.18 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-02-24
- Merck & Co., Inc. increase (decrease) in inventories for the quarter ending 2009-12-31 was -$1.08B, a 284.33% decline year-over-year.
- Merck & Co., Inc. increase (decrease) in inventories for the quarter ending 2009-09-30 was $148.00M.
- Merck & Co., Inc. increase (decrease) in inventories for the quarter ending 2008-12-31 was $587.00M.
- Merck & Co., Inc. increase (decrease) in inventories for the quarter ending 2008-09-30 was -$23.00M.
- Merck & Co., Inc. increase (decrease) in inventories for fiscal 2025 was $1.18B, a 41.32% increase from fiscal 2024.
- Merck & Co., Inc. increase (decrease) in inventories for fiscal 2024 was $835.00M, a 2.33% increase from fiscal 2023.
- Merck & Co., Inc. increase (decrease) in inventories for fiscal 2023 was $816.00M, a 406.83% increase from fiscal 2022.
- Merck & Co., Inc. increase (decrease) in inventories for fiscal 2022 was $161.00M, a 76.11% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $1.18B 10-K · filed 2026-02-24 | ||||
| 2024-12-31 | $835.00M 10-K · filed 2026-02-24 | ||||
| 2023-12-31 | $816.00M 10-K · filed 2026-02-24 | ||||
| 2022-12-31 | $161.00M 10-K · filed 2025-02-25 | ||||
| 2021-12-31 | $674.00M 10-K · filed 2024-02-26 | ||||
| 2020-12-31 | $895.00M 10-K · filed 2023-02-24 | $855.00M 10-K · filed 2021-02-25 | |||
| 2019-12-31 | $473.00M 10-K · filed 2022-02-25 | $508.00M 10-K · filed 2020-02-26 | |||
| 2018-12-31 | $911.00M 10-K · filed 2021-02-25 | ||||
| 2017-12-31 | $145.00M 10-K · filed 2020-02-26 | ||||
| 2016-12-31 | -$206.00M 10-K · filed 2019-02-27 | ||||
| 2015-12-31 | -$805.00M 10-K · filed 2018-02-27 | ||||
| 2014-12-31 | -$79.00M 10-K · filed 2017-02-28 | ||||
| 2013-12-31 | $365.00M 10-K · filed 2016-02-26 | ||||
| 2012-12-31 | $482.00M 10-K · filed 2015-02-27 | ||||
| 2011-12-31 | $678.00M 10-K · filed 2014-02-27 | ||||
| 2010-12-31 | -$1.99B 10-K · filed 2013-02-28 | ||||
| 2009-12-31 | -$1.08B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | -$934.00M derived: sum of 2 quarters · filed 2012-02-28 | -$1.21B 10-K · filed 2012-02-28 | $1.21B 10-K · filed 2010-03-01 | |
| 2009-09-30 | $148.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | -$129.00M 10-Q · filed 2009-10-29 | |||
| 2009-06-30 | -$277.00M 10-Q · filed 2009-07-24 | ||||
| 2008-12-31 | $587.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $564.00M derived: sum of 2 quarters · filed 2011-02-28 | $452.00M 10-K · filed 2011-02-28 | -$452.10M 10-K · filed 2010-03-01 | |
| 2008-09-30 | -$23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-29 | -$135.00M 10-Q · filed 2009-10-29 | |||
| 2008-06-30 | -$112.00M 10-Q · filed 2009-07-24 | ||||
| 2007-12-31 | -$40.70M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |